Navigation Links
Mindray Medical to Exhibit at Arab Health 2011 in Dubai from January 24-27

SHENZHEN, China, Jan. 18, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced its participation in the Arab Health 2011, to be held from January 24-27, 2011 in Dubai, U.A.E.

Arab Health is the most important annual medical exhibition in the Middle East.  In 2010, the event had over 2700 exhibitors and around 66,000 visitors from more than 79 countries. This year, Mindray will exhibit more than 50 devices from its three core product segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Five important products on exhibit are described below:

Patient monitoring and life support products:

  • the V series Patient Monitoring System
  • the WATO-EX 35 Anesthesia Machine
  • the BeneHeart D3 Defibrillator

  • In-Vitro diagnostic products:

  • the BS-800 Clinical Chemistry Analyzer
  • the BC-6800 Auto Hematology Analyzer

  • First launched in the US in the fourth quarter of 2010, the V series platform is a modular patient monitoring system, focusing on the philosophy of "easy-to-use" while incorporating traditionally highly complex monitoring parameters. The system is intended for intra hospital use under the direct supervision of a licensed healthcare practitioner. The system architecture allows users to customize, by removal or addition of modules, monitored parameters based on a patient's monitoring need or acuity level.

    First introduced in China, the WATO EX-35 anesthesia machine is suitable for general anesthesia in a wide range of patients from infants to adults. With its stable function, advanced safety design, reliable performance and user-friendly interface, the WATO gives clinical users basic monitoring measurements on a color LCD screen, with graphs of pressure and flow at the same time. In addition to basic ventilation modes, WATO also offers advanced modes applicable for patients' spontaneous breathing. The powerful data review supports 24-hour tracking for alarm events. Besides the integrated monitoring parameters, WATO also provides external monitoring covering EtCO2 and AG.

    BeneHeart D3 defibrillator was first launched in the international markets.  This defibrillator is for hospital usage and Mindray is currently the only Chinese manufacturer to have the capability to produce such product.  BeneHeart D3 is a compact, light weight defibrillator integrating manual defibrillation, monitoring, pacing and AED functions. Quick charging and shock delivery at customized energy levels ensures effective resuscitation. This vital signs monitoring function of ECG, SPO2 and respiration can improve diagnosis efficiency, and quickly indicates the effective defibrillation.

    First launched in China in the second quarter of 2010, the BS-800 Modular System combines innovation and high performance into an integrated solution. With an expandable platform, a more complete line of chemistry reagents, as well as calibrators and controls, the new solution package can be tailor-made to customer needs. Innovative features such as coaxial reagent disk, reagent bubble detection, dot light source and water quality monitor, are built in to ensure accuracy, convenience and cost-efficiency.

    Mindray will also showcase a demonstration unit of BC-6800, the new generation 5-part hematology system to be launched this year. The BC-6800 is a high level auto hematology analyzer with high processing speed. In addition to the routine CBC plus 5-Part Diff WBC test, the BC-6800's output can be extended in the form of Reticulocyte, Nucleated RBC, Optical Platelet count, etc, allowing wider clinical application and research.

    Attending the conference from Mindray will be Mr. Jie Liu, Chief Operating Officer. Mindray will be hosting booths MB10 and 4F10 at the Dubai International Convention & Exhibition Centre.

    "We are delighted to be attending this important international event to showcase our latest notable product launches and other promising products in the pipeline," commented Mr. Jie Liu, Mindray's Chief Operating Officer. "These products demonstrate that Mindray's focus on research continues to achieve success, as well as our commitment to deliver high price-to-performance ratio products to the markets worldwide."

    About MindrayWe are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit For investor and media inquiries please contactIn the U.S.:Hoki LukWestern Bridge, LLCTel:   +1-646-808-9150Email: hoki.luk@westernbridgegroup.comIn China:Cathy GaoMindray Medical International LimitedTel:   +86-755-2658-2620Email:

    SOURCE Mindray Medical International Limited
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
    2. Mindray Medical to Present at J.P. Morgan China Conference 2010
    3. Mindray Medical Provides Mid-Year Update on Product Development
    4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
    5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
    6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
    7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
    8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
    9. /C O R R E C T I O N - Mindray Medical International Limited /
    10. Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
    11. Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair
    Post Your Comments:
    (Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
    (Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
    (Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
    Breaking Medicine Technology:
    (Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
    (Date:10/12/2017)... ... , ... IsoComforter, Inc. ( ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
    (Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
    (Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
    (Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
    Breaking Medicine News(10 mins):